Cannabinoids protected nerve cells from chemotherapy damage in lab tests
Both synthetic and plant-derived cannabinoids preserved neuron viability (70-89% vs. 40% with chemo alone) and reduced axonal shortening from paclitaxel in cultured nerve cells.
Quick Facts
What This Study Found
When combined with paclitaxel, cannabinoids maintained cell viability at 70-89% compared to 40% with chemotherapy alone at 48 hours. Cannabinoids also preserved neurite length: paclitaxel alone shortened axons by 63%, while cannabinoid combinations limited shortening to 23-44%. Both synthetic (JWH-007, AM-694, MAB-CHMINACA) and phytocannabinoid preparations showed protective effects.
Key Numbers
Cell viability with cannabinoids + chemo: 70-89% vs. 40% chemo alone at 48 hours. Axon shortening: 23-44% with cannabinoid combination vs. 63% with paclitaxel alone. Both synthetic and plant-derived cannabinoids effective.
How They Did This
In vitro study using primary dorsal root ganglion neuron cultures. Cell viability assessed with multiple cannabinoids at various doses and timepoints. Neurite outgrowth measured to assess neuroprotection against paclitaxel-induced peripheral neuropathy.
Why This Research Matters
Chemotherapy-induced peripheral neuropathy affects 68% of paclitaxel patients and has no approved preventive treatment. If cannabinoids can protect nerves from chemo damage while maintaining cancer treatment, this could address a major unmet need in oncology.
The Bigger Picture
CIPN is one of the most common reasons cancer patients reduce or discontinue chemotherapy. A neuroprotective agent that does not interfere with anti-cancer effects would be a significant advance, and cannabinoids are candidates worth pursuing based on these preliminary data.
What This Study Doesn't Tell Us
In vitro study only; nerve cells in culture do not replicate the complexity of neuropathy in a living body. Cannot determine if cannabinoids would also protect cancer cells from chemotherapy. Optimal doses and timing for clinical use are unknown.
Questions This Raises
- ?Do cannabinoids protect cancer cells from chemotherapy at the same doses that protect neurons?
- ?Which specific cannabinoid formulation would be most effective and safe in cancer patients?
- ?Would in vivo animal models confirm these neuroprotective effects?
Trust & Context
- Key Stat:
- 70-89% neuron survival with cannabinoids vs. 40% with chemo alone
- Evidence Grade:
- Preliminary in vitro study with consistent neuroprotective findings across multiple cannabinoid types. Clinical translation requires animal studies and human trials.
- Study Age:
- Published in 2024 in Frontiers in Pharmacology.
- Original Title:
- The potential neuroprotective effects of cannabinoids against paclitaxel-induced peripheral neuropathy: in vitro study on neurite outgrowth.
- Published In:
- Frontiers in pharmacology, 15, 1395951 (2024)
- Authors:
- Creanga-Murariu, Ioana, Filipiuc, Leontina-Elena, Gogu, Maria-Raluca, Ciorpac, Mitica, Cumpat, Carmen Marinela, Tamba, Bogdan-Ionel, Alexa-Stratulat, Teodora
- Database ID:
- RTHC-05235
Evidence Hierarchy
Frequently Asked Questions
Can cannabinoids prevent chemo-related nerve damage?
In this lab study, both plant-derived and synthetic cannabinoids protected nerve cells from paclitaxel damage, maintaining viability at 70-89% compared to 40% without cannabinoids. Human studies are needed to confirm this.
Would cannabinoids interfere with chemotherapy?
This study focused on nerve protection and did not test whether cannabinoids also protect cancer cells. That question must be answered before clinical use.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-05235APA
Creanga-Murariu, Ioana; Filipiuc, Leontina-Elena; Gogu, Maria-Raluca; Ciorpac, Mitica; Cumpat, Carmen Marinela; Tamba, Bogdan-Ionel; Alexa-Stratulat, Teodora. (2024). The potential neuroprotective effects of cannabinoids against paclitaxel-induced peripheral neuropathy: in vitro study on neurite outgrowth.. Frontiers in pharmacology, 15, 1395951. https://doi.org/10.3389/fphar.2024.1395951
MLA
Creanga-Murariu, Ioana, et al. "The potential neuroprotective effects of cannabinoids against paclitaxel-induced peripheral neuropathy: in vitro study on neurite outgrowth.." Frontiers in pharmacology, 2024. https://doi.org/10.3389/fphar.2024.1395951
RethinkTHC
RethinkTHC Research Database. "The potential neuroprotective effects of cannabinoids agains..." RTHC-05235. Retrieved from https://rethinkthc.com/research/creanga-murariu-2024-the-potential-neuroprotective-effects
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.